X

Vous n'êtes pas connecté

Rubriques :

Maroc Maroc - HEALTHTECHZONE.COM - IT Professionals - 04/Nov 13:30

CytoDyn Announces FDA Clearance of Its Phase II Oncology Trial

Articles similaires

Sorry! Image not available at this time

Shorla Oncology Announces U.S. FDA Expanded Approval of Jylamvo (methotrexate), an Oncology and Autoimmune Drug for Pediatric Indications

drugs.com - 29/Oct 10:10

CAMBRIDGE, Mass.--(BUSINESS WIRE) October 29, 2024 --Shorla Oncology (‘Shorla’), a U.S.-Ireland specialty pharmaceutical company,...

Sorry! Image not available at this time

Repare Therapeutics reports updated positive safety and tolerability results from phase 1 MYTHIC trial

pharmabiz.com - 24/Oct 17:27

Repare Therapeutics Inc., a leading clinical─stage precision oncology company, presented updated data highlighting the benefits of its...

Sorry! Image not available at this time

QIAGEN receives FDA clearance of QIAstat-Dx meningitis/encephalitis panel to support emergency diagnostics

healthtechzone.com - 04/Nov 06:30

Sorry! Image not available at this time

Psyence Biomed Announces Recruitment of Second Clinical Trial Site for Ongoing Phase IIb Clinical Trial of Nature-Derived Psilocybin for Adjustment Disorder in Palliative Care

healthtechzone.com - 24/Oct 11:00

Sorry! Image not available at this time

Imugene hails 2-year “complete response” in cancer trial

thewest.com.au - 05/Nov 03:25

Clinical-stage immuno-oncology company Imugene is celebrating more than two years’ “complete response” for one of its bile tract cancer trial...

Sorry! Image not available at this time

Ondine Biomedical's US $11M Fundraise Enables a Q4 2024 Start of Its Pivotal Phase 3 US Trial

healthtechzone.com - 04/Nov 12:54

Sorry! Image not available at this time

Combining targeted therapy and immunotherapy improves overall survival in patients with anaplastic thyroid cancer

oncologynews.com.au - 05/Nov 17:33

Researchers from The University of Texas MD Anderson Cancer Centre, USA, demonstrated that anti-PD-L1 immunotherapy in combination with...

Sorry! Image not available at this time

Recce Phase II clinical trial reaches key dosing milestone

stockhead.com.au - 05/Nov 01:56

A Phase II clinical trial for acute bacterial skin and skin structure infections reaches a dosing milestone. ...

Sorry! Image not available at this time

HuidaGene Therapeutics gets US FDA clearance for CRISPR/Cas13 RNA─editing HG202 for macular degeneration

pharmabiz.com - 05/Nov 04:23

HuidaGene Therapeutics (HuidaGene), a global clinical─stage biotechnology company developing genome medicines, announced that the US FDA has cleared...

Sorry! Image not available at this time

Movano Health Plans Response Submission to FDA Next Week as Part of EvieMED Final Review Phase

healthtechzone.com - 24/Oct 12:00

Les derniers communiqués